Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotype.
Saved in:
| Title: | Risk factors and surrogate indicators for cardiovascular disease are prevalent in Common Variable Immunodeficiency and associate with inflammatory phenotype. |
|---|---|
| Authors: | Yu AJS; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Moreira F; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Symes A; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Curlewis K; Department of Radiology, Royal Free Hospital London NHS Foundation Trust, London, United Kingdom., O'Sullivan M; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Jayasundera J; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., El Rhermoul FZ; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Lever C; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Stoenchev K; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Chow KL; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Uysal OF; UCL Respiratory, University College London, London, United Kingdom., Alharbi AM; UCL Respiratory, University College London, London, United Kingdom., Workman S; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Halliday N; Sheila Sherlock Liver Centre, Royal Free London NHS Foundation Trust, London, United Kingdom.; University College London Institute for Liver and Digestive Health, University College London, London, United Kingdom., Laurence A; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Verma N; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Tadros S; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Kiani-Alikhan S; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Barnett J; Department of Radiology, Royal Free Hospital London NHS Foundation Trust, London, United Kingdom., Burns SO; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom., Hurst JR; UCL Respiratory, University College London, London, United Kingdom., Lowe DM; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.; Institute of Immunity and Transplantation, University College London, London, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 02; Vol. 17, pp. 1756049. Date of Electronic Publication: 2026 Mar 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
